Literature DB >> 6304563

Characteristics of [3H]fentanyl binding to the opiate receptor.

J W Villiger, L J Ray, K M Taylor.   

Abstract

The present study characterises the binding of the highly lipophilic opiate agonist [3H]fentanyl to homogenates of the rat central nervous system. At 25 degrees C, association of [3H]fentanyl with its binding site was rapid (t1/2 = 2.5 min). Dissociation from the binding site was biphasic (t1/2's = 4.0 and 100 min) suggesting the existence of high and low affinity binding sites. Scatchard plots of saturation isotherms were curvilinear, confirming the presence of high (KD = 0.46 nM) and low KD = 4.26 nM) affinity binding sites. Increasing temperature and the concentration of sodium ion decreased the [3H]fentanyl binding. Opiate agonists, antagonists and mixed agonist-antagonists were all potent (IC50's less than 20 nM) in displacing [3H]fentanyl and displacement by levorphanol and dextrorphan indicated that [3H]fentanyl binding was stereospecific. The mu and delta selective peptides, morphiceptin and [D-Ala2,D-Leu5]enkephalin, had IC50 values of 87 and 9.2 nM respectively. The regional distribution of [3H]fentanyl binding was in the rank order striatum approximately equal to midbrain greater than hypothalamus greater than cortex greater than hippocampus greater than brainstem greater than spinal cord greater than cerebellum. Comparison of [3H]fentanyl, [3H]naloxone and [3H-D-Ala2,D-Leu5]enkephalin binding in the hypothalamus-thalamus (mu-enriched) compared with the frontal cortex-striatum (delta-enriched) indicated that the pattern of [3H]fentanyl labelling was similar to that obtained with [3H]naloxone, but differed from that obtained with [3H-D-Ala2,D-Leu5]enkephalin. These characteristics suggest that [3H]fentanyl binds to the mu-opiate receptor. These findings are discussed in relation to the high lipid solubility of fentanyl as compared with morphine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304563     DOI: 10.1016/0028-3908(83)90162-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling.

Authors:  Fernando O Zelaya; Evangelos Zois; Christopher Muller-Pollard; David J Lythgoe; Sarah Lee; Caroline Andrews; Trevor Smart; Patricia Conrod; William Vennart; Steven C R Williams; Mitul A Mehta; Laurence J Reed
Journal:  MAGMA       Date:  2011-11-24       Impact factor: 2.310

2.  The effect of different anesthetics on neurovascular coupling.

Authors:  Maria Angela Franceschini; Harsha Radhakrishnan; Kiran Thakur; Weicheng Wu; Svetlana Ruvinskaya; Stefan Carp; David A Boas
Journal:  Neuroimage       Date:  2010-03-27       Impact factor: 6.556

Review 3.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 4.  Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.

Authors:  R B Muijsers; A J Wagstaff
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Fentanyl-induced conditional place preference: lack of associated conditional neurochemical events.

Authors:  J M Finlay; A Jakubovic; A G Phillips; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Opioid receptors and myocardial protection: do opioid agonists possess cardioprotective effects?

Authors:  K J McCormack; C B Chapleo
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

7.  Radioreceptor assay of narcotic analgesics in serum.

Authors:  J Grevel; J Thomas; M L Richards; W Sadée
Journal:  Pharm Res       Date:  1984-09       Impact factor: 4.200

8.  Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.

Authors:  Denis Antoine; Andrew S Huhn; Eric C Strain; Gavin Turner; Jasmyne Jardot; Alexis S Hammond; Kelly E Dunn
Journal:  Am J Addict       Date:  2020-06-23

Review 9.  Opioids in COVID-19: Two Sides of a Coin.

Authors:  Camila Vantini Capasso Palamim; Matheus Negri Boschiero; Aléthea Guimarães Faria; Felipe Eduardo Valencise; Fernando Augusto Lima Marson
Journal:  Front Pharmacol       Date:  2022-01-06       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.